David presented at a recent Oxford Bio Network (OBN) BioTuesday Seminar, “De-risking the Valley of Death – How R&D Companies can access the Knowledge Network to Maximise Success” as part of a delegation from the BioHub at Alderley Park. The seminar’s focus was on how collaboration and working together can help cross the drug development “Valley of Death”. David’s presentation focused on how Blueberry has built an extensive network of collaborations to bring in expertise and help them progress their lead anti-fungal programme to clinical testing in a very cost effective and efficient way.
